New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
11:23 EDTPETXAratana Therapeutics management to meet with Jefferies
Meeting to be held in New York on March 26 hosted by Jefferies.
News For PETX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
16:31 EDTPETXOn The Fly: Closing Wrap
Subscribe for More Information
12:27 EDTPETXOn The Fly: Midday Wrap
Subscribe for More Information
09:28 EDTPETXOn The Fly: Pre-market Movers
Subscribe for More Information
December 18, 2014
18:22 EDTPETXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Red Hat (RHT), up 9.3%... Pier 1 Imports (PIR), up 8%... NQ Mobile (NQ), up 9.3%... Cintas (CTAS), up 6.3%. ALSO HIGHER: Aratana Therapeutics (PETX), up 25.9% after candidate for dog osteoarthritis shows positive results... Ally Financial (ALLY), up 5% after announcing that it will exit the Troubled Asset Relief Program. DOWN AFTER EARNINGS: Nike (NKE), down 2.7%. ALSO LOWER: American Apparel (APP), down 2.8% after New York Post reports on takeover bid.
16:55 EDTPETXAratana Therapeutics' candidate for dog osteoarthritis shows positive results
Aratana Therapeutics announced positive results from its pivotal field study of AT-001 - Grapiprant -, the company's drug for treating pain in dogs with osteoarthritis. In the study, dogs receiving AT-001 demonstrated improvements in pain assessment scores that were statistically significant compared to placebo at a once-daily oral dose. Aratana expects to commence commercialization upon FDA approval, which Aratana anticipates in 2016.
December 16, 2014
16:30 EDTPETXAratana Therapeutics initiates pivotal study for AT-003
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use